Showing results (2501-2510 of 4,197) with videos related to
Sort By:
Pageof 420
Home Healthcare Now|July 7, 2018
Preparing Clinicians for Transitioning Patients Across Care Settings and Into the Home Through SimulationMargory A Molloy, Michael P Cary, Jill Brennan-Cook, et al.The Oncologist|July 18, 2018
Disparities in the Use of Programmed Death 1 Immune Checkpoint InhibitorsJeremy M O'Connor, Kathi Seidl-Rathkopf, Aracelis Z Torres, et al.Frontiers in Plant Science|April 5, 2018
The Aspergillus flavus Spermidine Synthase (spds) Gene, Is Required for Normal Development, Aflatoxin Production, and Pathogenesis During Infection of Maize KernelsRajtilak Majumdar, Matt Lebar, Brian Mack, et al.BMC Geriatrics|August 24, 2021
Older women's experiences of companion animal death: impacts on well-being and aging-in-placeDonna M Wilson, Leah Underwood, Eloise Carr, et al.Journal of Geriatric Oncology|June 15, 2020
Did quality of life for older cancer survivors improve with the turn of the century in the United States?Amandeep R Mahal, Laura D Cramer, Elyn H Wang, et al.Virology|February 1, 2011
A cyclin-binding motif in human papillomavirus type 18 (HPV18) E1^E4 is necessary for association with CDK-cyclin complexes and G2/M cell cycle arrest of keratinocytes, but is not required for differentiation-dependent viral genome amplification or L1 capsid protein expressionGillian L Knight, Alice G Pugh, Emma Yates, et al.Cancer|March 13, 2016
Disease-related costs of care and survival among Medicare-enrolled patients with myelodysplastic syndromesAmer M Zeidan, Rong Wang, Amy J Davidoff, et al.Cancer|February 23, 2012
Correlation of drug-induced apoptosis assay results with oncologist treatment decisions and patient response and survivalLinda D Bosserman, Swapnil P Rajurkar, Karl Rogers, et al.Cancer|September 16, 2015
Outcomes of postchemotherapy retroperitoneal lymph node dissection following high-dose chemotherapy with stem cell transplantationClint Cary, Jose A Pedrosa, Joseph Jacob, et al.Journal of Medicinal Chemistry|March 31, 2017
Discovery of Novel 1,4-Diacylpiperazines as Selective and Cell-Active eIF4A3 InhibitorsMasahiro Ito, Toshio Tanaka, Douglas R Cary, et al.Pageof 420